The impact of infliximab therapy on colonic mucosal expression of barrier genes in patients with inflammatory bowel disease.

Arijs, I.; Quintens, R.; Van Lommel, L.; Van Steen, Kristel; De Hertogh, G.; Van Assche, G.; vermeire, S.; Geboes, K.; Schuit, F.; Rutgeerts, P.

Other (Scientific journals)

Arijs, I.; Quintens, R.; Van Lommel, L. et al.

2009 • In Acta Gastro-Enterologica Belgica

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/56524

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Arijs2009_BW.pdf

Author preprint (41.93 kB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Disciplines :

Gastroenterology & hepatology

Author, co-author :

Arijs, I.

Quintens, R.

Van Lommel, L.

Van Steen, Kristel ; Université de Liège - ULiège > Dép. d'électric., électron. et informat. (Inst.Montefiore) > Bioinformatique

De Hertogh, G.

Van Assche, G.

vermeire, S.

Geboes, K.

Schuit, F.

Rutgeerts, P.

Language :

English

Title :

The impact of infliximab therapy on colonic mucosal expression of barrier genes in patients with inflammatory bowel disease.

Publication date :

2009

Journal title :

Acta Gastro-Enterologica Belgica

ISSN :

0001-5644

eISSN :

1784-3227

Publisher :

Acta Medica Belgica, Bruxelles, Belgium

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 26 May 2010

Statistics

Number of views

46 (3 by ULiège)

Number of downloads

2 (0 by ULiège)

More statistics